Hofseth BioCare ASA Cash Flow Statement

Financials in millions NOK. Fiscal year is January - December.

Millions NOK. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Net Income	-130.32	-125.3	-106.68	-137.39	-126.46	-102.09
Depreciation & Amortization	32.23	32.79	29.87	24.41	25.72	23.36
Other Amortization	6.99	6.99	6.54	5.81	3.63	3.41
Loss (Gain) From Sale of Assets	0.09	-8.12	-23.49	-	-	-
Asset Writedown & Restructuring Costs	-	-	-	0.19	-	-
Loss (Gain) on Equity Investments	1.95	7.48	2.54	-0.2	-0.03	0.78
Other Operating Activities	164.73	159.68	9.49	9.95	9.39	8.66
Change in Accounts Receivable	6.73	-4	-0.78	-3.98	4.18	-8.73
Change in Inventory	-10.46	26.63	33.98	-25.71	-17.51	-39.32
Change in Accounts Payable	59.31	38.47	-90.59	70.36	39.21	55.25
Change in Other Net Operating Assets	-152.62	-144.4	141.87	11.4	0.1	-2.96
Operating Cash Flow	-21.39	-9.78	2.76	-45.17	-61.78	-61.63
Capital Expenditures	-9.99	-2.44	-8.19	-4.02	-22.92	-32.58
Sale (Purchase) of Intangibles	-1.72	-1.63	-5.87	-13.76	-14.83	-21.88
Investment in Securities	-	-	-1.62	-	-0.19	-5.6
Other Investing Activities	-0	-0	0.69	-	-	-
Investing Cash Flow	-11.71	-4.07	-14.99	-17.78	-37.94	-60.06
Short-Term Debt Issued	-	19.4	28.35	-	-	-
Long-Term Debt Issued	-	25.1	-	-	1.09	39.02
Total Debt Issued	101.75	44.5	28.35	-	1.09	39.02
Long-Term Debt Repaid	-	-12.98	-14.18	-15.05	-14.89	-70.64
Net Debt Issued (Repaid)	95.84	31.52	14.17	-15.05	-13.8	-31.62
Issuance of Common Stock	-	-	-	70.78	-	245.65
Other Financing Activities	-20.65	-15.98	-10.48	-10.28	-9.39	-14.06
Financing Cash Flow	75.19	15.54	3.69	45.45	-23.2	199.97
Miscellaneous Cash Flow Adjustments	-	0	-	-	0	-
Net Cash Flow	42.1	1.69	-8.54	-17.49	-122.91	78.28
Free Cash Flow	-31.37	-12.22	-5.43	-49.19	-84.7	-94.21
Free Cash Flow Margin	-12.60%	-4.60%	-2.49%	-40.84%	-96.67%	-136.03%
Free Cash Flow Per Share	-0.08	-0.03	-0.01	-0.13	-0.24	-0.28
Cash Interest Paid	20.65	15.69	9.49	9.95	9.39	8.58
Levered Free Cash Flow	8.22	21.85	-100.88	-72.21	-65.15	-94.57
Unlevered Free Cash Flow	21.11	31.66	-96.16	-65.99	-59.28	-88.81
Change in Working Capital	-97.04	-83.31	84.49	52.06	25.97	4.25

Source: S&P Global Market Intelligence. Standard template. Financial Sources.